ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267183.1	AKT inhibitor VIII	Chronic Lymphocytic Leukemia	0.006793474	Resistant
ENSG00000267183.1	AKT inhibitor VIII	Lung squamous cell carcinoma	0.015380296	Resistant